Tidefelt U - Search Results

1

Lindgren S, Brännström T, Hanse E, Ledin T, Nilsson G, Sandler S, Tidefelt U, Donnér J. Lindgren S, et al. Among authors: tidefelt u. Med Teach. 2011;33(10):798-803. doi: 10.3109/0142159X.2011.570816. Med Teach. 2011. PMID: 21942478

2

Treatment, long-term outcome and prognostic variables in 214 unselected AML patients in Sweden.

Aström M, Bodin L, Nilsson I, Tidefelt U. Aström M, et al. Among authors: tidefelt u. Br J Cancer. 2000 Apr;82(8):1387-92. doi: 10.1054/bjoc.1999.1123. Br J Cancer. 2000. PMID: 10780515 Free PMC article.

3

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Juliusson G, Antunovic P, Derolf A, Lehmann S, Möllgård L, Stockelberg D, Tidefelt U, Wahlin A, Höglund M. Juliusson G, et al. Among authors: tidefelt u. Blood. 2009 Apr 30;113(18):4179-87. doi: 10.1182/blood-2008-07-172007. Epub 2008 Nov 13. Blood. 2009. PMID: 19008455 Free article.

4

Evidence for a bimodal relation between serum lysozyme and prognosis in 232 patients with acute myeloid leukaemia.

Aström M, Bodin L, Hörnsten P, Wahlin A, Tidefelt U. Aström M, et al. Among authors: tidefelt u. Eur J Haematol. 2003 Jan;70(1):26-33. doi: 10.1034/j.1600-0609.2003.02780.x. Eur J Haematol. 2003. PMID: 12631256

5

Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population.

Aström M, Bodin L, Tidefelt U. Aström M, et al. Among authors: tidefelt u. Leuk Lymphoma. 2001 May;41(5-6):559-70. doi: 10.3109/10428190109060346. Leuk Lymphoma. 2001. PMID: 11378573

6

Differences in CD14 and alpha-naphthyl acetate esterase positivity and relation to prognosis in AML.

Fergedal M, Aström M, Tidefelt U, Karlsson MG. Fergedal M, et al. Among authors: tidefelt u. Leuk Res. 1998 Jan;22(1):25-30. doi: 10.1016/s0145-2126(97)00100-8. Leuk Res. 1998. PMID: 9585076

7

Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial.

Löfgren C, Paul C, Aström M, Hast R, Hedenius M, Lerner R, Liliemark J, Nilsson I, Rödjer S, Simonsson B, Stockelberg D, Tidefelt U, Björkholm M. Löfgren C, et al. Among authors: tidefelt u. Br J Haematol. 2004 Feb;124(4):474-80. doi: 10.1111/j.1365-2141.2004.04805.x. Br J Haematol. 2004. PMID: 14984497 Free article. Clinical Trial.

8

BCRP mRNA expression v. clinical outcome in 40 adult AML patients.

Uggla B, Ståhl E, Wågsäter D, Paul C, Karlsson MG, Sirsjö A, Tidefelt U. Uggla B, et al. Among authors: tidefelt u. Leuk Res. 2005 Feb;29(2):141-6. doi: 10.1016/j.leukres.2004.06.004. Leuk Res. 2005. PMID: 15607361

9

Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia.

Tidefelt U, Elmhorn-Rosenborg A, Paul C, Hao XY, Mannervik B, Eriksson LC. Tidefelt U, et al. Cancer Res. 1992 Jun 15;52(12):3281-5. Cancer Res. 1992. PMID: 1596886

10

Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.

Karlsson K, Strömberg M, Liliemark J, Delannoy A, Johnson SA, Porwit A, Kimby E, Lärfars G, Cristiansen I, Nilsson G, Celsing F, Sundström G, Luthman M, Tidefelt U, Wallvik J, Juliusson G. Karlsson K, et al. Among authors: tidefelt u. Br J Haematol. 2002 Mar;116(3):538-48. doi: 10.1046/j.0007-1048.2001.03296.x. Br J Haematol. 2002. PMID: 11849209 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page